Rare autoantibodies to cellular antigens in systemic lupus erythematosus

Lupus

Volumn 23, Issue 7, 2014, Pages 672-677

  Fredi, M ^a,b,c   Cavazzana, I ^a   Quinzanini, M ^a   Taraborelli, M ^a,b,c   Cartella, S ^a   Tincani, A ^a,b   Franceschini, F ^a  

^a Rheumatology and Clinical Immunology Unit   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Anti ENA; Anti Ki; Anti Ku; Rare antibodies; Subset disease; Systemic lupus Erythematosus

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL ANTIGEN; ENA ANTIBODY; JO 1 ANTIBODY; KI ANTIBODY; KU ANTIBODY; LA ANTIBODY; PROTEIN ANTIBODY; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; RIBOSOME PROTEIN P ANTIBODY; RO ANTIBODY; SM ANTIBODY; UNCLASSIFIED DRUG; ANTIGEN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; COUNTER IMMUNOELECTROPHORESIS; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DISCOID LUPUS ERYTHEMATOSUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; HEP 2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MULTIVARIATE ANALYSIS; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; RASH; RAYNAUD PHENOMENON; SENSITIVITY AND SPECIFICITY; SEROLOGY; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; XEROPHTHALMIA; XEROSTOMIA; BLOOD; CELLS; IMMUNOLOGY; RETROSPECTIVE STUDY;

ADULT; ANTIGENS; AUTOANTIBODIES; CELLS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RETROSPECTIVE STUDIES;

EID: 84903605592     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314524850     Document Type: Article

References (31)

1. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004; 34: 501-537.
2. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 2005; 52: 4003-4010
3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
4. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677-2686.
5. Cavazzana I, Fredi M, Taraborelli M, Quinzanini M, Tincani A, Franceschini F. A subset of systemic Sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku antibodies. Clin Exp Rheumatol 2013; 31: 118-121.
6. Mahler M, Miyachi K, Peebles C, Fritzler MJ. The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA). Autoimmun Rev 2012; 11: 771-775.
7. Gussin HA, Ignat GP, Varga J, Teodorescu M. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 376-383.
8. Fritzler MJ, McCarty GA, Ryan JP, Kinsella TD. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen. Arthritis Rheum 1983; 26: 140-145.
9. Mahler M, Silverman ED, Schulte-Pelkum J, Fritzler MJ. Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality? Autoimmun Rev 2010; 9: 756-760.
10. Bernstein RM, Bunn CC, Hughes GRV. Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis 1982; 41: 554-555.
11. Clark G, Reichlin M, Tomasi TB. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969; 102: 117-122.
12. Venables PJW, Smith PR, Maini RN. Purification and characterization of the Sjögren's syndrome A and B antigens. Clin Exp Immunol 1983; 54: 731-738.
13. Tan EM. International cooperative activities standardization of antinuclear antibodies. In: Van Verroij WJ, Maini RN (eds), Manual of biological markers of disease. A1. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1993. pp. 1-5.
14. Tincani A, Allegri F, Sanmarco M, et al. Anticardiolipin antibody assay: A methodological analysis for a better consensus in routine determinations - a cooperative project of the European Antiphospholipid Forum. Thromb Haemost 2001; 86: 575-583.
15. Balestrieri G, Tincani A, Spatola L, et al. Anti-beta 2 glycoprotein I antibodies: A marker of antiphospholipid syndrome? Lupus 1995; 4: 122-130
16. Gerli R, Caponi L, Tincani A, et al. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: Prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) 2002; 41: 1357-1366.
17. Riboldi P, Asero R, Origgi L, Crespi S. The SL/Ki system in connective tissue diseases: Incidence and clinical associations. Clin Exp Rheumatol 1987; 5: 29-33.
18. Cavazzana I, Franceschini F, Vassalini C, et al. Clinical and serological features of 35 patients with anti-Ki autoantibodies. Lupus 2005; 14: 837-841.
19. Matsudaira R, Takeuchi K, Takasaki Y, Yano T, Matsushita M, Hashimoto H. Relationships between autoantibody responses to deletion mutants of Ki antigen and clinical manifestations of lupus. J Rheumatol 2003; 30: 1208-1214.
20. Yamanaka K, Takasaki Y, Nishida Y, Shimada K, Shibata M, Hashimoto H. Detection and quantification of anti-Ki antibodies by enzyme-linked immunosorbent assay using recombinant Ki antigen. Arthritis Rheum 1992; 6: 667-671.
21. Sakamoto M, Takasaki Y, Yamanaka K, Kodama A, Hashimoto H, Hirose S. Purification and characterization of Ki antigen and detection of anti-Ki antibody by enzyme-linked immunosorbent assay in patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1554-1562.
22. Wang J, Satoh M, Kabir F, et al. Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2367-2370.
23. Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis- scleroderma overlap. J Clin Invest 1981; 68: 611-620.
24. Franceschini F, Cavazzana I, Generali D, et al. Anti-Ku Antibodies in Connective Tissue Diseases: Clinical and Serological Evaluation of 14 Patients. J Rheumatol 2002; 29: 1393-1397.
25. Cavazzana I, Ceribelli A, Quinzanini M, et al. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. Lupus 2008; 17: 727-732.
26. Arnett FC, Hamilton RG, Roebber MG, Harley JB, Reichlin M. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988; 15: 1773-1776.
27. Thompson D, Juby A, Davis P. The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus 1993; 2: 15-19.
28. Tang X, Huang Y, Deng W, Tang L, Weng W, Zhang X. Clinical and serologic correlations and autoantibody clusters in systemic lupus erythematosus: A retrospective review of 917 patients in South China. Medicine (Baltimore) 2010; 89: 62-67.
29. Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C. Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford) 2003; 42: 276-279.
30. Respaldiza N, Wichmann I, Ocaña C, et al. Anti-centromere antibodies in patients with systemic lupus erythematosus. Scand J Rheumatol 2006; 35: 290-294.
31. Nakano M, Ohuchi Y, Hasegawa H, Kuroda T, Ito S, Gejyo F. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. J Rheumatol 2000; 27: 1403-1407.